Submit Your Paper Editorial Board Publication Fee Archive

Indexed in

Follower of

Committee on Publication Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources: Reviewers

July 2026, Vol 12, No. 2

Original

1. Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

Mohamed M Darwish , Atef Y Riad, Dina A Salem, Ahmad E Essa, Marwa M Shakweer* , Diaa Eldin M. Sherif

Immunopathol Persa. 2022;8(1): e18. doi: 10.34172/ipp.2022.18

Scopus ID: 85119256857

Article

PDF

XML

Cited By:

Original

2. Clinicopathological correlation and prognostic value of PD-L1 expression in renal cell carcinoma

Hoda Sayed Elkhodary , Khaled E Nasr, Sherif H Ahmed, Marwa M Shakweer* , Mai MA Ezz-Eldin

Immunopathol Persa. 2022;8(2): e30329. doi: 10.34172/ipp.2022.30329

Scopus ID: 85133718100

Article

PDF

XML

Cited By:

Original

3. Tumor budding in gastric adenocarcinoma; reflections on tumor microenvironment and programmed death ligand 1 (PD-L1) expression

Safaa M.M. Abd El Khalek* , Mariam I. Halim

Immunopathol Persa. 2023;9(1): e31365. doi: 10.34172/ipp.2022.31365

Scopus ID: 85145178185

Article

PDF

XML

Cited By:

Original

4. Expression of programmed death-ligand 1 and epidermal growth factor receptor in head and neck squamous cell carcinoma; an immunohistochemical and clinicopathological study

Ismail Mohamed Ismail* , Hussein Abdel-moneim Hassan , Sarah AlFarabi Ali , Madawi Alkeheli , Sahar Bukhary , Ahoud Jazzar , Nada A. Alhindi , Hanan Ali Amin , Bahaa Mohammed Badr , Jana Fathelbab , Ghada Sabbah Ibrahim Radwan , Nadia Attia Radi

Immunopathol Persa. 2026;12(2): e43772. doi: 10.34172/ipp.2025.43772

Article

PDF

XML

Cited By: